Apellis Pharmaceuticals
APLS
#3568
Rank
โ‚น246.56 B
Marketcap
โ‚น1,964
Share price
1.41%
Change (1 day)
-57.69%
Change (1 year)

EPS for Apellis Pharmaceuticals (APLS)

EPS in 2023 (TTM): -โ‚น433.24

According to Apellis Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -โ‚น448.40. In 2022 the company made an earnings per share (EPS) of -โ‚น523.56 an increase over its 2021 EPS that were of -โ‚น755.88.

EPS history for Apellis Pharmaceuticals from 2017 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น433.24-17.25%
2022-โ‚น523.56-30.73%
2021-โ‚น755.8892.81%
2020-โ‚น392.03-11.73%
2019-โ‚น444.13123.18%
2018-โ‚น199.0127.08%
2017-โ‚น156.59

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-โ‚น186.19-58.48%๐Ÿ‡บ๐Ÿ‡ธ USA